A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers

The Canadian budget impact analysis (BIA) guidelines were published by the Patented Medicine Prices Review Board (PMPRB) in 2007. Some Canadian federal, provincial and territorial (F/P/T) drug plans have updated their BIA guidelines since then. The aim of the present review was to provide a comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales: Foroutan, Naghmeh, Tarride, Jean-Eric, Xie, Feng, Mills, Fergal, Levine, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861390/
https://www.ncbi.nlm.nih.gov/pubmed/31041614
http://dx.doi.org/10.1007/s41669-019-0139-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861390/
https://www.ncbi.nlm.nih.gov/pubmed/31041614
http://dx.doi.org/10.1007/s41669-019-0139-y

Ejemplares similares